Summary

This article reviews the role of thermogenic agents in the management of cardiometabolic risk. The global obesity pandemic represents a major public health problem, in particular since overweight and obesity are well-known risk factors that predispose patients to cardiovascular diseasse and type 2 diabetes [Seale P, Lazar MA. Diabetes 2009].